From: Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia
Reference | DNA methylation detection methods | AML group | Prognostic genes regulated by DNA methylation |
---|---|---|---|
Figueroa et al. [16] | HELP | 344 Newly diagnosed AML | BLR1 (CXCR5), BTBD3, E2F1, FAM110A, FAM30A, GALNT5, KIAA1305, LCK, LMCD1, PRMT7, SLC7A6OS, SMG6, SRR, USP50, VWF, ZFP161 |
Li et al. [9] | ERRBS | 138 Paried AML (diagnosis and relapse) | CCDC85C, CHL1, ELAVL2, FAM115A, FAM196A, GPR146, GPR6, HELZ2, ID4, IL2RA, KCNG3, LOC254559, LOC284801, NPAS2, PCDHAC2, PROB1, SHISA6, SLC18A3, SOCS2, TRIM67, ZFP42 |
Marcucci et al. [50] | MethylCap-seq | 134 CN-AML (355 CN-AML validated) | AATK, ACAP3, ADCK2, ADCY6, AGPAT9, AHCY, ALOX15B, ANXA6, APBB1, APOD, AQP11, ARHGAP27, AXL, BRF1, C15orf62, C17orf77, C8orf51, CABLES1, CARD11, CD34 a, CHMP7, CISH, CLDN15, CLEC3B, DDIT4, DHCR24, DHRS12, EGFL7, ETS1, EVC, F2RL1 a, FAM92A1 a, FCHO1, FKBP4, FLVCR1, FLVCR1-AS1, FZD6, GAL3ST3, GCNT2, GIT1, GPR56, H1F0, HCN2, HIVEP3, IQSEC1, KCNK6, KDM2B, KLHL3, KNCN, LOC646627, MDFI, ME3, MEOX1, MIR126, MIR155HG a, MVD, NAV1, NBL1, NLRP1, PLK3, PMM1, PRKCZ, PRKG2, RAB36, RGS3, RHOC a, RHPN1, SCARF1, SCRN1 a, SH3TC1, SPRY1, SRC, TBL2, TCEA3, TENC1, UBXN6, VWA8 a, WDR16, WDR86, WRAP53, ZNF623, ZNF70 |